DISGUSTING: Study finds that animal vaccines have no safeguards against contamination and contribute to serious pet diseases like cancer
(Natural News) Most of us are incredibly attached to our pets. As such, we do everything we can to prevent them from getting ill, including getting them vaccinated at the intervals recommended on the schedules we receive from their veterinarians. What we might not realize, however, is that in getting them vaccinated we may be... (Source: NaturalNews.com)
Source: NaturalNews.com - April 22, 2018 Category: Consumer Health News Source Type: news

World Immunization Week 2018: Protected Together, #VaccinesWork
22 April 2018, Cairo – This year’s World Immunization Week campaign, celebrated from 24 to 30 April, aims to highlight that protecting entire communities with vaccines protects everyone and so the theme of this year’s campaign is “Protected Together, #VaccinesWork”.  Immunization is one of the most successful and cost-effective health interventions. Studies show that every US$ 1 spent on childhood immunization returns US$ 44 in economic and social benefits.  Immunization protects everyone – from infants to senior citizens – against disabling illnesses, disability a...
Source: WHO EMRO News - April 22, 2018 Category: Middle East Health Source Type: news

GE Rides Gene Therapy Wave With Ready-made Viral Drug Factories GE Rides Gene Therapy Wave With Ready-made Viral Drug Factories
General Electric is raising its bet on biotechnology with the launch of prefabricated manufacturing units for producing virus-based gene and cell therapies, novel anti-cancer treatments and vaccines.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 19, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Promising Personalized Ovarian Cancer Vaccine Induces Immune Responses
A personalized cancer vaccine was well tolerated and was capable of inducing antitumor T-cell immunity in patients with recurrent ovarian cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 19, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Gynecologic Cancers SiteTerms/www.cannabissciencetech.com/News Ovarian Cancer Source Type: news

Tanzania:Over 30,000 Girls to Be Administered With Cervical Cancer Vaccine in Mwanza
[Citizen] Mwanza -Regional authorities here will administer at least 31,291 girls aged 14 with a vaccine to protect them from developing cervical cancer. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 18, 2018 Category: African Health Source Type: news

Latest Mesothelioma Immunotherapy Combination Looks Promising
Scientists at the Vaccine and Immunotherapy Center (VIC) at Massachusetts General Hospital have uncovered a novel, two-agent immunotherapy combination that worked surprisingly well in animal models with malignant mesothelioma. The discovery has sparked new optimism for immunotherapy, which has struggled to provide consistently positive results with aggressive cancers such as mesothelioma. “This is the beginning of a new story of hope, a new combination of immunotherapy,” Dr. Mark Poznansky, director of the VIC and associate professor at Harvard Medical School, told Asbestos.com. “It worked quite well in a...
Source: Asbestos and Mesothelioma News - April 17, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

GE rides gene therapy wave with ready-made viral drug factories
LONDON (Reuters) - General Electric is raising its bet on biotechnology with the launch of prefabricated manufacturing units for producing virus-based gene and cell therapies, novel anti-cancer treatments and vaccines. (Source: Reuters: Health)
Source: Reuters: Health - April 17, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Morris Animal Foundation awards $775K to test osteosarcoma immunotherapy vaccine in dogs
(Morris Animal Foundation) Morris Animal Foundation has awarded a $775,000 grant to the University of Pennsylvania to test a vaccine that could improve longevity and quality of life for dogs with the deadly bone tumor, osteosarcoma. The research team will conduct clinical trials to evaluate a novel immunotherapy treatment which combines a molecule expressed by cancer cells with a modified live form of the bacteria Listeria monocytogenes. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 17, 2018 Category: Biology Source Type: news

Medical News Today: Personalized vaccine fights off cancer in clinical trial
A groundbreaking new pilot study designs personalized tumor vaccines for people with late-stage ovarian cancer. The results are promising. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 13, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Personalized vaccine doubly effective at prolonging lives of women with advanced ovarian cancer
In a University of Pennsylvania study women who received personalized vaccines in combination with chemo had double the two-year survival rate of those treated with chemo alone. (Source: the Mail online | Health)
Source: the Mail online | Health - April 12, 2018 Category: Consumer Health News Source Type: news

A personalized vaccine helps patients fight back against ovarian cancer
In early research that extends the possibilities of immunotherapy to a killer feared by women, a personalized vaccine helped patients with ovarian cancer mount a stronger defense against their tumors and substantially improved their survival rate.The vaccine was tested in a preliminary clinical... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - April 12, 2018 Category: Science Authors: Melissa Healy Source Type: news

Personalized tumor vaccine shows promise in pilot trial
A new type of cancer vaccine has yielded promising results in an initial clinical trial conducted at the Perelman School of Medicine at the University of Pennsylvania and the Abramson Cancer Center of the University of Pennsylvania. The personalized vaccine is made from patients' own immune cells, which are exposed in the laboratory to the contents of the patients' tumor cells, and then injected into the patients to initiate a wider immune response. (Source: World Pharma News)
Source: World Pharma News - April 12, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Ovarian cancer vaccine shows promising results in human study
Immunotherapy has gained ground against a stubborn opponent: ovarian cancer. A personalized cancer vaccine is safe and may lengthen the lives of ovarian cancer patients, a small clinical trial found. (Source: CNN.com - Health)
Source: CNN.com - Health - April 11, 2018 Category: Consumer Health News Source Type: news

Ovarian cancer vaccine shows promising results
Immunotherapy has gained ground against a stubborn opponent: ovarian cancer. A personalized cancer vaccine is safe and may lengthen the lives of ovarian cancer patients, a small clinical trial found. (Source: CNN.com - Health)
Source: CNN.com - Health - April 11, 2018 Category: Consumer Health News Source Type: news

Tanzania:600,000 Girls for Cervical Cancer Vaccination
[Cameroon Tribune] Tanzania has launched a cervical cancer vaccination drive covering more than 600,000 girls aged 14 years and below, the BBC reported on April 10, 2018. Cervical cancer is the most common cancer in Tanzania and the leading cause of cancer-related disease and deaths among women. Worldwide, more than 260,000 women die of cervical cancer annually, which is preventable and treatable if detected in early stages. The government hopes that the campaign will reduce health costs. Treating a cervical cancer patient c (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 11, 2018 Category: African Health Source Type: news

Personalized tumor vaccine shows promise in pilot trial
(University of Pennsylvania School of Medicine) A new type of cancer vaccine has yielded promising results in an initial clinical trial. The personalized vaccine is made from patients' own immune cells, which are exposed to the contents of the patients' tumor cells, and injected into the patients to initiate a wider immune response. The trial, conducted in advanced ovarian cancer patients, showed that about half of the vaccinated patients had signs of anti-tumor T-cell responses. The study is published today in Science Translational Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 11, 2018 Category: International Medicine & Public Health Source Type: news

Ludwig researchers devise and test pioneering personalized ovarian cancer vaccine
(Ludwig Institute for Cancer Research) A Ludwig Cancer Research study has shown that an entirely new type of personalized cancer vaccine induces novel, potent and clinically effective immune responses in patients receiving a combination of standard therapies for recurrent, stage III and IV ovarian cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 11, 2018 Category: International Medicine & Public Health Source Type: news

Training the immune system to fight ovarian cancer
(American Association for the Advancement of Science) A personalized cancer vaccine safely and successfully boosted immune responses and increased survival rates in patients with ovarian cancer, according to results from a pilot clinical trial. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 11, 2018 Category: Cancer & Oncology Source Type: news

Tanzania:Cervical Cancer Vaccination Drive Starts in Tanzania
[Citizen] Dar Es Saam -Vice President, Ms Samia Suluhu, has today, April 10, launched national drive to provide cervical cancer vaccine to all women aged 14 and above. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 10, 2018 Category: African Health Source Type: news

UTSA researchers explore little-known, deadly fungal infections
(University of Texas at San Antonio) A new study by Althea Campuzano, Ph.D., a student at the University of Texas at San Antonio, and Floyd Wormley, Jr., Professor of Biology and Senior Associate Dean for Research and Graduate Studies, sheds light on little-known fungal infections caused by the fungus Cryptococcus. There are currently no vaccines available for any fungal infection, which can be extremely deadly to patients under treatment for diseases like HIV, AIDS and cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 10, 2018 Category: Cancer & Oncology Source Type: news

Zimbabwe:Govt's Cervical Cancer Vaccination Targets 800,000 Girls
[New Zimbabwe] The Government has launched a vaccination programme for cervical cancer meant to address high infections and related deaths among women in Zimbabwe. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 9, 2018 Category: African Health Source Type: news

Tanzania:Health Ministry Lays Emphasis On Jabs Against Cervical Cancer
[Daily News] THE Ministry of Health has urged all parents to ensure that their daughters were vaccinated against cervical cancer during the upcoming nationwide campaign. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 4, 2018 Category: African Health Source Type: news

New compound helps activate cancer-fighting T cells
(University of Connecticut) An international research team led by University of Connecticut chemist Amy Howell has created a new lipid antigen that helps stimulate disease-fighting T cells in the immune system, opening up new paths for the development of better cancer therapy drugs and vaccines. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 2, 2018 Category: Cancer & Oncology Source Type: news

Could cancer "vaccine" that cured tumors in mice work for people?
Treatment that worked in 97 percent of lab mice reportedly will be tested in people later this year (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 29, 2018 Category: Consumer Health News Source Type: news

North Africa:Cervical Cancer to Double Across Middle East Without Vaccines
[Thomson Reuters Foundation] Beirut -Deaths from cervical cancer will double in the Middle East and North Africa by 2035 unless conservative nations vaccinate young women and tackle sexual taboos, a study said on Wednesday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - March 28, 2018 Category: African Health Source Type: news

Cancer vaccine that cured 97% of tumours in mice will be tested on humans  
Researchers from Stanford University are developing a vaccine that activates the immune system to attack tumours. It contains two drugs proven for their safety, with side effects expected to be just fever. (Source: the Mail online | Health)
Source: the Mail online | Health - March 28, 2018 Category: Consumer Health News Source Type: news

Boys Still Aren ’t Getting the HPV Vaccine As Much As Girls, Study Says
When the HPV vaccine first hit the U.S. market in 2006, it was approved only for girls. Boys got the green light three years later — but a new study suggests there’s still a gender gap in vaccination rates. The HPV vaccine — administered in either two or three doses — protects against human papillomavirus, a common sexually transmitted disease that can lead to cervical, vaginal, anal, penile, mouth and throat cancers. The Centers for Disease Control and Prevention (CDC) recommends that all children get the vaccine when they’re 11 or 12 years old, though it’s approved for use in people up...
Source: TIME: Health - March 27, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime public health Source Type: news

Health care providers less likely to offer HPV vaccination to teenage boys: Study
Skipping the vaccine could potentially be putting them at risk of cancer. (Source: ABC News: Health)
Source: ABC News: Health - March 27, 2018 Category: Consumer Health News Tags: Health Source Type: news

Many Doctors Don't Push HPV Shots To Boys
HPV is a sexually transmitted virus that can cause cervical, vulvar, vaginal, penile, anal, mouth and throat cancers. The HPV vaccine is recommended as a routine childhood vaccination. (Source: WebMD Health)
Source: WebMD Health - March 26, 2018 Category: Consumer Health News Source Type: news

Personalized vaccines for cancer immunotherapy
Cancer is characterized by an accumulation of genetic alterations. Somatic mutations can generate cancer-specific neoepitopes that are recognized by autologous T cells as foreign and constitute ideal cancer vaccine targets. Every tumor has its own unique composition of mutations, with only a small fraction shared between patients. Technological advances in genomics, data science, and cancer immunotherapy now enable the rapid mapping of the mutations within a genome, rational selection of vaccine targets, and on-demand production of a therapy customized to a patient’s individual tumor. First-in-human clinical trials o...
Source: ScienceNOW - March 22, 2018 Category: Science Authors: Sahin, U., Türeci, O. Tags: Medicine, Diseases special/review Source Type: news

Harvard bioengineers' biomaterial-based cancer immunotherapies to be developed by Novartis
(Wyss Institute for Biologically Inspired Engineering at Harvard) The Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) announced today that Novartis will have access to commercially develop their therapeutic, biomaterial-based, cancer vaccine technology that promotes anti-cancer immunity. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 20, 2018 Category: International Medicine & Public Health Source Type: news

The use of immunotherapy to treat metastatic breast cancer
(Bentham Science Publishers) The Authors review immunotherapy attempts to treat metastatic breast cancer. They include a) the addition of cytokines to endocrine therapy, b) monoclonal antibodies associated to chemotherapy and c) vaccination. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 19, 2018 Category: Cancer & Oncology Source Type: news

Newly described human antibody prevents malaria in mice
(NIH/National Institute of Allergy and Infectious Diseases) Scientists have discovered a human antibody that protected mice from infection with the deadliest malaria parasite, Plasmodium falciparum. The research findings provide the basis for future testing in humans to determine if the antibody can provide short-term protection against malaria, and also may aid in vaccine design. NIAID investigators led the research with colleagues at the Fred Hutchinson Cancer Research Center. Currently, there is no highly effective, long-lasting vaccine to prevent malaria. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 19, 2018 Category: Infectious Diseases Source Type: news

Immunotherapy for Prostate Cancer: Where Do We Go From Here? —PART 1: Prostate Cancer Vaccines
The first article in this two-part series will provide an overview of both past and present therapeutic vaccination strategies for the promotion of antitumor immunity against prostate cancer. (Source: CancerNetwork)
Source: CancerNetwork - March 15, 2018 Category: Cancer & Oncology Authors: Amar Patel, MD Lawrence Fong, MD Tags: Genitourinary Cancers Oncology Journal Prostate Cancer Review Article Source Type: news

How Exercising Into Old Age Can Keep Your Immune System Young
Exercise, even in old age, is known to have a wide range of health benefits, from preventing disability to slowing memory decline. But a new study reveals that it can also protect the immune system. In the study, published in the journal Aging Cell, researchers looked at 125 very active adult cyclists who were between ages 55 and 79. The researchers analyzed their blood for markers of T-cells, which are known to help the immune system fight infections. The study authors then compared the cyclists to people in their same age group who did not exercise regularly, as well as younger adults between ages 20 and 36. Not only was...
Source: TIME: Health - March 9, 2018 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized Exercise/Fitness healthytime Source Type: news

Stem Cell Vaccine Carries Potential as Mesothelioma Treatment
Researchers at the Stanford University School of Medicine believe a patient-specific stem cell vaccine could become part of mesothelioma treatment — and possibly prevention — in the future. The belief stems from their recent study that demonstrated a consistent immunologic response with genetically-altered stem cells in laboratory mice carrying particular cancer cells. “This could potentially play a role for a large group of — if not all — cancers,” Dr. Joseph Wu, director of the Stanford Cardiovascular Institute, told Asbestos.com. “We envision it potentially being used as a vacci...
Source: Asbestos and Mesothelioma News - March 6, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Breakthrough drug could be 'vaccine for prostate cancer'
The research is at an early stage, but scientists from Queen ’s University Belfast believe their findings could be used to vaccinate young men against getting prostate cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - March 6, 2018 Category: Consumer Health News Source Type: news

Australia could become first country to eradicate cervical cancer
Free vaccine program in schools leads to big drop in rates, although they remain high in the developing world• Ian Frazer: Eliminating cervical cancer globally is within reachAustralia could become the first country to eradicate cervical cancer, according to an announcement from the International Papillomavirus Society.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 3, 2018 Category: Science Authors: Naaman Zhou Tags: Cervical cancer Health Cancer research Australia news Medical research Science Source Type: news

Virus-like particle could lead to new cancer vaccine
(Michigan State University) Michigan State University scientists are engineering a virus-like particle, known as Qβ, that will generate anti-cancer immune responses in the body and potentially be used as a new vaccine for the treatment of cancer. The project, funded by a $2.4 million grant from the National Cancer Institute, will support the development of the vaccine to protect animals against cancerous cells that are currently untreatable, and could easily translate to vaccines for humans' use of spontaneously occurring cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 2, 2018 Category: Cancer & Oncology Source Type: news

HPV Causes Cancer — A Vaccine Can Prevent It
More than 30,000 Americans develop one of several kinds of cancer each year caused by the human papillomavirus (HPV) — some of which will kill them. Fortunately, physicians say a too-seldom-used vaccine can protect people from HPV-caused cancers of the cervix, vulva, vagina, penis, anus, and oropharynx (head and neck). (Source: TMA News Room)
Source: TMA News Room - March 1, 2018 Category: Consumer Health News Source Type: news

Denmark campaign rebuilds confidence in HPV vaccination
When Eigil Rosegar Poulsen first heard about the controversy over the human papilloma virus (HPV) vaccination in Denmark, he became quite upset. Still, the debate sparked a desire to share his story. In 2010 Eigil lost his wife, Trine, to cervical cancer —a disease caused by the HPV virus—leaving him to raise their three daughters alone. Though the WHO-recommended vaccine against the most common types of the virus was only introduced in Denmark’s child vaccination schedule in 2009, far too late for his wife to benefit, Eigil is a strong advoc ate for vaccination. (Source: WHO Feature Stories)
Source: WHO Feature Stories - February 28, 2018 Category: International Medicine & Public Health Tags: adolescent health [subject], adolescent, youth, young people, teen health, teenager, adolescence, adolescents, cancer [subject], cervical cancer, cervical cancer [subject], cervical tumour, cervical neoplasm Source Type: news

Autologous Anti-Tumor Vaccines Derived from Induced Pluripotent Stem Cells Could Aid in Cancer Prevention
In a mouse model, researchers were able to prevent certain cancers using a vaccine made from induced pluripotent stem cells in combination with an immunostimulant agent. (Source: CancerNetwork)
Source: CancerNetwork - February 27, 2018 Category: Cancer & Oncology Authors: John Schieszer Tags: Immuno Oncology News Source Type: news

Many cases of "dementia" are actually side effects of prescription drugs or vaccines, according to research
(Natural News) The “quick facts” provided by the Alzheimer’s Association are pretty concerning: More than five million people in America are living with Alzheimer’s, and that number is projected to reach 16 million by the year 2050. As the sixth leading cause of death in our nation, it kills more Americans than prostate cancer and... (Source: NaturalNews.com)
Source: NaturalNews.com - February 27, 2018 Category: Consumer Health News Source Type: news

Shocking vaccine safety warning
(Natural News) More than ever, the American population is plagued by debilitating health problems like, Lyme’s disease, chronic fatigue syndrome, autism, cancer and dementia – that were virtually unheard of just a few generations ago. Why? Some say it’s genetics; some say it’s environmental pollution; while others say it’s due to the current (ever-growing) vaccine... (Source: NaturalNews.com)
Source: NaturalNews.com - February 23, 2018 Category: Consumer Health News Source Type: news

Can you vaccinate yourself against cancer?
Studies touting the benefits of cancer vaccines are emerging, but do those studies really show hope or just hype? Here's a look at the past, present and future of cancer vaccine research. (Source: CNN.com - Health)
Source: CNN.com - Health - February 21, 2018 Category: Consumer Health News Source Type: news

Cancer vaccines: Where do we stand?
Studies touting the benefits of cancer vaccines are emerging, but do those studies really show hope or just hype? Here's a look at the past, present and future of cancer vaccine research. (Source: CNN.com - Health)
Source: CNN.com - Health - February 21, 2018 Category: Consumer Health News Source Type: news

This Vaccine Can Prevent Cancer, But Many Teenagers Still Don't Get It
The HPV vaccine can prevent cervical cancer in women and some cancers in men. It's most effective when given early in adolescence. But a new analysis finds only 29 percent of teens get it by age 13.(Image credit: The Washington Post/The Washington Post/Getty Images) (Source: NPR Health and Science)
Source: NPR Health and Science - February 19, 2018 Category: Consumer Health News Authors: Allison Aubrey Source Type: news

Kenya:Rollout of Cancer Vaccine Deferred as Demand Grows
[Nation] A national rollout of free cervical cancer vaccine that was to kick off this year has been pushed to 2019, the Sunday Nation has learnt. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 19, 2018 Category: African Health Source Type: news

So-called "cancer vaccine" isn't a vaccine at all; it's actually immunotherapy that boosts the body's own immune function
(Natural News) There is no doubt that a cancer diagnosis is absolutely devastating. Sadly, most of us have been affected by this disease, either directly or through having to watch a friend or family member suffer with it. It is therefore understandable that the idea of a cancer vaccine would be wholeheartedly embraced by most... (Source: NaturalNews.com)
Source: NaturalNews.com - February 18, 2018 Category: Consumer Health News Source Type: news

Another Cancer Vaccine Shows Promise In Mice
Title: Another Cancer Vaccine Shows Promise In MiceCategory: Health NewsCreated: 2/15/2018 12:00:00 AMLast Editorial Review: 2/16/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 16, 2018 Category: Cancer & Oncology Source Type: news